Empadi 10 mg (Tablet)
Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Pacific pharmaceuticals ltd |
| Also available as |
Indications
- Improving glycemic control in type 2 diabetes mellitus
- Reducing risk of cardiovascular death in type 2 diabetes mellitus patients with established cardiovascular disease
Pharmacology
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Reduces renal absorption of glucose
- Contributes to reduced hyperglycemia, weight loss, and reduced blood pressure
Dosage & Administration
- Recommended dose of 10 mg once daily
- Can be taken with or without food
- Dose may be increased to 25 mg once daily in tolerant patients
Interaction
- Increased urine volume when co-administered with diuretics
- Increased risk of hypoglycemia when co-administered with insulin or insulin secretagogues
Contraindications
- Hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Limited studies in pregnant women
- Use during pregnancy only if benefits outweigh potential risks
- Not recommended during breastfeeding
Precautions & Warnings
- Assessment of renal function recommended before initiation
- Avoid in patients with eGFR less than 45 ml/min/1.73 m²
- No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m²
Overdose Effects
- Usual supportive measures in case of overdose
- Hemodialysis has not been studied for Empagliflozin removal
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store below 30°C, protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
Common Questions about Empadi 10 mg Tablet
- Used to improve glycemic control in adults
- Unsafe to use during pregnancy
- Unsafe to use during breastfeeding
- Cautious use in patients with underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
Quick Tips
- Used alone or with other diabetes medicines
- May cause dehydration, hypoglycemia, genital fungal infections, and UTIs
- Monitor blood sugar regularly
- Inform doctor about specific symptoms